← Leaderboards
Gary Lazar
Vitalex Biosciences, Llc
$1,793,436
Attributed
$3,586,872
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1000K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,586,872 · 2
By mechanism
R44$2,987,094 · 1
R43$599,778 · 1
Top collaborators
- Ashraf S. Ibrahim5 shared
Most similar at Vitalex Biosciences, Llc
Same institution · by research overlap
- Marwan Nasralla$151,113
Others in their field
Other Emerging Leaders on “Glucose-Regulated Proteins”
- Marcelo Pablo Coba · University Of Southern California$3,216,898
- Shailesh Agarwal · University Of Nevada Reno$2,765,373
- Giedre Krenciute · St. Jude Children'S Research Hospital$1,999,395
- Simon G. Stone · Giner, Inc.$1,309,343
- Adebowale O Bamidele · Mayo Clinic Rochester$723,101
- Sandro Belvedere · Forkhead Biotherapeutics, Inc.$584,112
Research focus
Glucose-Regulated ProteinsIgg1Diabetes MellitusFundingHumanized Monoclonal AntibodiesHuman TissueCross ReactivityAffinityDiabetic KetoacidosisEndothelial CellsCgmp ProductionHematogenousAntifungal TherapyAntigensAnimal ModelClinical TrialsBindingBiological SciencesAntibodiesCell LineDisease ProgressionBrainAdrenal Cortex HormonesImmunocompromised Host
Grant awards (5)
Humanized monoclonal antibodies to treat mucormycosis$999,218
R44 · FY2025 · AI · contact PI
Humanized monoclonal antibodies to treat mucormycosis$999,975
R44 · FY2024 · AI · contact PI
Humanized monoclonal antibodies to treat mucormycosis$987,901
R44 · FY2023 · AI · contact PI
Humanized monoclonal antibodies to treat mucormycosis$299,778
R43 · FY2019 · AI · contact PI
Humanized monoclonal antibodies to treat mucormycosis$300,000
R43 · FY2018 · AI · contact PI